Targeted Financial Statements From 2010 to 2026
| TRGM Stock | USD 0.0001 0.00 0.00% |
Check Targeted Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Targeted Medical's main balance sheet or income statement drivers, such as , as well as many indicators such as . Targeted financial statements analysis is a perfect complement when working with Targeted Medical Valuation or Volatility modules.
Targeted |
Targeted Medical Company Return On Asset Analysis
Targeted Medical's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Targeted Medical Return On Asset | -0.48 |
Most of Targeted Medical's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Targeted Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Targeted Medical has a Return On Asset of -0.4796. This is 94.52% lower than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The return on asset for all United States stocks is notably higher than that of the company.
Targeted Medical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Targeted Medical's current stock value. Our valuation model uses many indicators to compare Targeted Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Targeted Medical competition to find correlations between indicators driving Targeted Medical's intrinsic value. More Info.Targeted Medical is currently regarded as top stock in return on asset category among its peers. It is rated second in profit margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Targeted Medical's earnings, one of the primary drivers of an investment's value.About Targeted Medical Financial Statements
Targeted Medical investors utilize fundamental indicators, such as revenue or net income, to predict how Targeted Pink Sheet might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Targeted Medical Pharma, Inc., a specialty pharmaceutical company, doing business as Physician Therapeutics, develops and commercializes amino acid based medications to physicians, pharmacies, and patients in the United States. Targeted Medical Pharma, Inc. was founded in 1996 and is headquartered in Los Angeles, California. Targeted Medical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 30 people.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetOther Information on Investing in Targeted Pink Sheet
Targeted Medical financial ratios help investors to determine whether Targeted Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Targeted with respect to the benefits of owning Targeted Medical security.